Product
Regimen A
1 clinical trial
1 indication
Indication
Multidrug-resistant tuberculosisClinical trial
STREAM: The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBStatus: Completed, Estimated PCD: 2022-05-13